Columbia Contrarian Core-I3COFYX
13F holders, Q3 2024 (September 30)1holders
0new positions
0sold out
$38.85avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Columbia Contrarian Core-I3 (COFYX) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holder was Coston, McIsaac & Partners ($138K).
- Company
- Columbia Contrarian Core-I3
- CUSIP
- 19766M709
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 1,563 shares sold, net −1,563 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Coston, McIsaac & Partners | 0.04% | Reduce -30.6% | 3,552 | $138K |
"% of holder's portfolio" is COFYX's weight in each manager's 13F, not the share of Columbia Contrarian Core-I3 the manager owns.